Estrogen inhibits interleukin-6 production and gene expression in a human osteoblastic cell line with high levels of estrogen receptors

Journal of Bone and Mineral Research

Volumn 11, Issue 2, 1996, Pages 193-199

  Kassem, Moustapha ^a   Harris, Steven A ^b   Spelsberg, Thomas C ^b   Riggs, B Lawrence ^a  

^a MAYO CLINIC   (United States)

^b MAYO GRADUATE SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIESTROGEN; ESTRADIOL; ESTROGEN; ESTROGEN RECEPTOR; FULVESTRANT; HYDROCORTISONE; INTERLEUKIN 1BETA; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; BONE MARROW CELL; BONE TURNOVER; CELL TYPE; CONTROLLED STUDY; DOSE RESPONSE; ESTROGEN ACTIVITY; ESTROGEN DEFICIENCY; FETUS; GENE EXPRESSION REGULATION; HORMONAL REGULATION; HUMAN; HUMAN CELL; NORTHERN BLOTTING; OSTEOBLAST; OSTEOLYSIS; POSTMENOPAUSE OSTEOPOROSIS;

EID: 0030020568     PISSN: 08840431     EISSN: None     Source Type: Journal    
DOI: 10.1002/jbmr.5650110208     Document Type: Article

References (33)

1. Heaney RP, Recker RR, Saville PD 1978 Menopausal changes in bone remodelling. J Lab Clin Med 92:964-970.
2. Eriksen E, Colvard DS, Berg NJ, Graham ML, Mann KG, Spelsberg TC, Riggs BL1988 Evidence of estrogen receptors in normal human osteoblast-like cells. Science 241:84-86.
3. Keeling PE, Scott RE, Colvard S, Han I-K, Spelsberg TC, Riggs BL 1991 Lack of a direct effect of estrogen on proliferation and differentiation of normal human osteoblast-like cells. J Bone Miner Res 6:297-304.
4. Manolagas SC, Jilka RL 1995 Bone marrow, cytokines, and bone remodeling: emerging insights into the pathophysiology of osteoporosis. New Engl J Med 332:305-311.
5. Girasole G, Jilka RL, Passen G, Bowell S, Boder G, Williams DS, Manolagas SC 1992 17β-Estradiol inhibits interleukin-6 production by bone marrow-derived stromal cells and osteoblasts in vitro: a potential mechanism for the antiosteoporotic effect of estrogens. J Clin Invest 89:883-891.
6. Passeri G, Girasole G, Jilka RL, Manolagas SC 1993 Increased interieukin-6 production by murine bone marrow and bone cells after estrogen withdrawal. Endocrinology 133:822-828.
7. Pottratz S, Bellido T, Mocharla H, Crabb DS, Manolagas SC 1994 17β-estradiol inhibits expression of human interleukin-6 promoter-reporter constructs by a receptor-dependent mechanism. J Clin Invest 93:944-950.
8. Ray A, Prefontaine KE, Ray P 1994 Down-modulation of interleukin-6 gene expression by 17β-estradiol in the absence of high affinity DNA binding by the estrogen receptor. J Biol Chem 269:12940-12946.
9. Rickard D, Russell G, Gowen M 1992 Oestradiol inhibits the release of tumor necrosis factor but not interleukin 6 from adult human osteoblasts in vitro. Osteoporos Int 2:94-102.
10. Chaudhary LR, Spelsberg TC, Riggs BL 1992 Production of various cytokines by normal human osteoblast-like cells in response to interleukin-1β and tumor necrosis factor-α: Lack of regulation by 17β-estradiol. Endocrinology 130: 2528-2534.
11. Rifas L, Kenney JS, Marcelli M, Pacifici R, Cheng SL, Dawson LL, Avioli LV 1995 Production of interleukin-6 in human osteoblasts and human bone marrow stromal cells: evidence that induction by interleukin-1 and tumor necrosis factor-alpha is not regulated by ovarian steroids. Endocrinology 136:4056-4067.
12. Jilka RL, Hangoc G, Girasole G, Passeri G, Williams DC, Abrams JS, Boyce B, Broxmeyer, H, Manolagas SC 1992 Increased osteoclast development after estrogen loss: mediation by interleukin-6. Science 257:88-91.
13. Kitazawa R, Kimble RB, Vannice JL, Kung VT, Pacifici R 1994 Interleukin-1 receptor antagonist and tumor necrosis factor binding protein decrease osteoclast formation and bone resorption in ovariectomized mice. J Clin Invest 94: 2397-2406.
14. 3. Endocrinology 133:053-562.
15. Davis VL, Couse JF, Gray TK, Korach KS 1994 Correlation between low levels of estrogen receptors and estrogen responsiveness in two rat osteoblast-tike cell lines. J Bone Miner Res 9:983-991.
16. Ernst M, Parker MG, Rodan GA 1991 Functional estrogen receptors in osteoblastic cells demonstrated by transfection with a reporter gene containing an estrogen response element. Mol Endocrinol 5:1597-1606.
17. Migliaccio S, Davis VL, Gibson MK, Gray TK, Korach KS 1992 Estrogens modulate the responsiveness of osteoblast-like cells (ROS 17/2.8) stably transfected with estrogen receptor. Endocrinology 130:2617-2624.
18. Harris SA, Tau KR, Enger RJ, Toft DO, Riggs BL, Spelsberg TC 1995 Estrogen response in the hFOB 1.19 human fetal osteoblastic cell line stably transfected with the human estrogen receptor gene. J Cell Biochem 59:193-201.
19. Harris SA, Enger RJ, Riggs BL, Spelsberg TC 1995 Development and characterization of a conditionally immortalized human fetal osteoblastic cell line. J Bone Miner Res 10:178-186.
20. Chomczynski P, Sacchi N 1987 Single-step method of RNA isolation and by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156-159.
21. Alderson MR, Tough TW, Ziegler SF, Grabstein KH 1991 Interleukin-7 induces cytokine secretion and tumoricidal activity by human peripheral blood monocytes. J Exp Med 173:923-930.
22. Kassem M, Bhum W, Risteli J, Mosekilde L, Eriksen EF 1993 Growth hormone stimulates proliferation and differentiation of normal human osteoblast-like cells in vitro. Calcif Tissue Int 52:222-226.
23. Poli V, Balena R, Fattori E, Markatos A, Yamamoto M, Tanaka H, Ciliberto G, Rodan GA, Costantini F 1994 Interleukin-6 deficient mice are protected from bone loss caused by estrogen depletion. EMBO J 13:1189-1196.
24. Mane PJ, Hott M, Launay JM, Graulet AM, Gueris J 1993 In vitro production of cytokines by bone surface-derived osteoblastic cells in normal and osteoporotic postmenopausal women: relationship with cell proliferation. J Clin Endocrinol Metabol 77:824-830.
25. McKane WR, Khosla S, Peterson JM, Egan K, Riggs BL 1994 Circulating levels of cytokines that modulate bone resorption: effects of age and menopause in women. J Bone Miner Res 9:1313-1318.
26. Khosla S, Peterson JM, Egan K, Jones JD, Riggs BL 1994 Circulating cytokine levels in osteoporotic and normal women. J Clin Endocrinol Metabol 79:707-711.
27. Horowitz MC 1993 Cytokines and estrogen in bone: antiosteoporotic effects. Science 260:626-627.
28. Pacifici R 1992 Is there a causal role for IL-1 in postmenopausal bone loss?. Calcif Tissue Int 50:295-299.
29. Roodman GD 1992 Interleukin-6: An osteotropic factor? J Bone Miner Res 7:475-478.
30. Oursler MJ, Cortese C, Keeting P, Anderson MA, Bonde SK, Riggs BL, Spelsberg TC 1991 Modulation of transforming growth factor-β production in normal human osteoblast-like cells by 17β-estradiol and parathyroid hormone. Endocrinology 129:3313-3320.
31. Oreffo ROC, Bonewald L, Kukita A, Garrett IR, Seyedin SM, Rosen D, Mundy GR 1990 Inhibitory effects of the bone-derived growth factors osteoinductive factor and transforming growth factor-β on isolated osteoclasts. Endocrinology 126: 3069-3075.
32. Oursler MJ, Pedersen L, Fitzpatrick L, Riggs BL, Spelsberg TC 1994 Human giant cell tumours of the bone (osteoclastomas) are estrogen target cells. Proc Natl Acad Sci USA 91:5227-5231.
33. Oursler MJ, Osdoby P, Pyfferoen J, Riggs BL, Spelsberg TC 1991 Avian osteoclasts as estrogen target cells. Proc Natl Acad Sci USA 88:6613-6617.